Anixa Biosciences Inc. logo

Anixa Biosciences Inc. (ANIX)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
3. 46
-0.24
-6.4865%
$
119.76M Market Cap
- P/E Ratio
- Div Yield
432,722 Volume
-0.37 Eps
$ 3.7
Previous Close
Add Transaction
Day Range
3.33 3.82
Year Range
2.32 5.46
Want to track ANIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know

Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know

Anixa Biosciences (ANIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 5 days ago
New Strong Buy Stocks for July 22nd

New Strong Buy Stocks for July 22nd

HTLD, YEXT, ANIX, WVE and LCNB have been added to the Zacks Rank #1 (Strong Buy) List on July 22, 2026.

Zacks | 5 days ago
Here's Why You Should Add ANIX Stock to Your Portfolio Now

Here's Why You Should Add ANIX Stock to Your Portfolio Now

Anixa advances cancer vaccines and CAR-T therapies, supported by positive early data, a planned phase II study and expanding intellectual property protection.

Zacks | 1 month ago
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript

Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript

Anixa Biosciences, Inc. ( ANIX ) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs November 11, 2025 2:00 PM EST Company Participants Amit Kumar - CEO, Chairman & Co-Chair of CBAB Conference Call Participants Robert Sassoon - Water Tower Research LLC Presentation Robert Sassoon Water Tower Research LLC Hello, everybody. I'm Robert Sassoon.

Seekingalpha | 8 months ago
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Zacks | 8 months ago
Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice

Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice

Does ANIXA BIOSCIENCES INC (ANIX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 9 months ago
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and Mind Medicine (MindMed) Inc. (MNMD) have performed compared to their sector so far this year.

Zacks | 1 year ago
Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?

Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.

Zacks | 1 year ago
ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy?

ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy?

Does ANIXA BIOSCIENCES INC (ANIX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.

Zacks | 1 year ago
What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now?

What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now?

Does ANIXA BIOSCIENCES INC (ANIX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy

All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy

Anixa Biosciences (ANIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 1 year ago
Loading...
Load More